Electrocardiographic infarct size assessment after thrombolysis: Insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial

American Heart Journal

Volumn 150, Issue 4, 2005, Pages 659-665

  Barbagelata, Alejandro ^a   Di Carli, Marcelo F ^b   Califf, Robert M ^c   Garg, Jyotsna ^c   Birnbaum, Yochai ^d   Grinfeld, Liliana ^a   Gibbons, Raymond J ^e   Granger, Christopher B ^c   Goodman, Shaun G ^f   Wagner, Galen S ^c   Mahaffey, Kenneth W ^c  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e MAYO CLINIC   (United States)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ALGORITHM; ARTICLE; BLOOD CLOT LYSIS; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCARDIOGRAM; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; MULTICENTER STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; VALIDATION PROCESS;

ADENOSINE; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 25844494504     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.10.014     Document Type: Article

References (29)

1. R.J. Gibbons, T.F. Christian, and M.R. Hopfenspirger Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention J Am Coll Cardiol 24 1994 616
2. P. Marzullo, G. Sambuceti, and O. Parodi The role of sestamibi scintigraphy in the radio isotopic assessment of myocardial viability J Nucl Med 33 1992 1925 1930
3. R.J. Gibbons, D.R. Holmes, and G.S. Reeder Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction N Engl J Med 328 1993 685 691
4. G.L. Schaer, L.J. Spaccavento, and K.F. Browne Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial Circulation 94 1996 298 307
5. K.W. Mahaffey, J.A. Puma, and N.A. Barbagelata Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial J Am Coll Cardiol 34 1999 1711 1720
6. P. Clemmensen, P. Grande, and K. Sauamaki Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts J Am Coll Cardiol 16 1990 1252 1257
7. D.C. Sevilla, N.B. Wagner, and K.S. Pieper Use of the 12-lead ECG to detect myocardial reperfusion and salvage during acute myocardial infarction J Electrocardiol 25 1992 281 286
8. P. Clemmensen, M.E. Ohman, and D. Sevilla Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction Am J Cardiol 70 1992 1391 1396
9. F.W. Bar, P.G. Volders, and P. Hoppener Development of ST-segment elevation and Q and R wave changes in acute myocardial infarction and the influence of thrombolytic therapy Am J Cardiol 77 1996 337 343
10. H.R. Aldrich, N.B. Wagner, and J. Boswick Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarct Am J Cardiol 61 1988 749 753
11. P. Clemmensen, P. Grande, and H.R. Aldrich Evaluation of formulas for estimating the final size of acute myocardial infarcts from quantitative ST-segment elevation on the initial standard 12-lead ECG J Electrocardiol 24 1991 77 83
12. N.B. Hindman, D.S. Douglas, and M. Widmann Evaluation of a QRS scoring system for estimating myocardial infarct size: V. Specificity and method of application of the complete system Am J Cardiol 55 1985 1485 1490
13. D.C. Sevilla, N.B. Wagner, and R. Pegues Correlation of the complete version of the Selvester QRS scoring system with quantitative anatomic findings for multiple left ventricular myocardial infarcts Am J Cardiol 69 1992 465 469
14. J.L. Willems, R.J. Willems, and I. Bijnens Value of electrocardiographic scoring systems for the assessment of thrombolytic therapy in acute myocardial infarction. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator Eur Heart J 12 1991 378 388
15. C.P. Juergens, C. Fernandes, and E. Hasche Electrocardiographic measurement of infarct size after thrombolytic therapy J Am Coll Cardiol 1 1996 617 624
16. S. Tateishi, S. Abe, and T. Yamashita Use of the QRS scoring system in the early estimation of myocardial infarct following reperfusion J Electrocardiol 30 1997 315 322
17. T.F. Christian, I.P. Clements, and T. Behrenbeck Limitations of the electrocardiogram in estimating infarction size following acute reperfusion therapy Ann Intern Med 114 1991 264 270
18. T.F. Christian, R.J. Gibbons, and I.P. Clements Estimates of myocardium at risk and collateral flow in acute myocardial infarction using electrocardiographic indexes with comparison to radionuclide and angiographic measures J Am Coll Cardiol 26 1995 338 393
19. J. De Sutter, C. Van de Wiele, and P. Gheeraert The Selvester 32-point QRS score for evaluation of myocardial infarct size after primary coronary angioplasty Am J Cardiol 83 1999 255 257
20. C. Altehofer, H.J. Kaiser, and R. Dorr Fluorine-18-deoxiglucose PET for assessment of viable myocardium in perfusion defects in 99m Tc Mibi SPECT: a comparative study in patients with coronary artery disease Eur J Nucl Med 19 1992 334 342
21. S.G. Sawada, K. Allman, and O. Muziki Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects J Am Coll Cardiol 23 1994 92 98
22. Y. Birnbaum, and G.S. Wagner The initial electrocardiographic pattern in acute myocardial infarction: correlation with infarct size J Electrocardiol 32 Suppl. 1999 122 128
23. R.J. Temple A regulatory authority's opinion about surrogate end points W.S. Nimmo G.T. Tucker Clinical measurement in drug evaluation 1985 Wiley New York
24. E.J. Topol, S.G. Ellis, and R.M. Callif Combined tissue type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group J Am Coll Cardiol 14 1989 877 884
25. T.C. Wall, R.M. Callif, and J. Blankenship Intravenous fluosol in the treatment of acute myocardial infarction. Results of the thrombolysis and angioplasty in myocardial infarction 9 trial Circulation 90 1994 114 120
26. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS: a randomized factorial trial assessing early oral captoprill, oral mononitrate and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
27. Collaborative Organization for RheothRx Evaluation (CORE) Effects of RheothRx on mortality, morbidity, left ventricular function and infarct size in patients with acute myocardial infarction Circulation 96 1997 192 201
28. EMIP-FR Pilot Study Group Free radicals, reperfusion and myocardial infarction therapy: European myocardial infarction project-free radicals pilot study Eur Heart J (Suppl G) 1993 48 51
29. G.L. Schaer, L.J. Spaccavento, and K.F. Browne Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarct results of a randomized double-blind, placebo-controlled trial Circulation 94 1996 298 307